Patent AnalyticsExaminers
Rankings

Company or institution

Celtaxsys, Inc.

22 applicationsfiled 2009 to 2019

Allowance rate
50%
−25 pts vs the USPTO range 31% to 69%
Rejections before allowance
1.2
−0.4 vs the USPTO
Months to first action
7.8 mo
−10.8 vs the USPTO
Needed an RCE
18%
−9 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds11 apps
A61K Medical preparations6 apps
C07C 4 apps
C07K Peptides1 apps

Art units

16259 apps
16283 apps
16432 apps
16222 apps
16242 apps
16292 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
16263546PENDANT AMINES AND DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE2019-01-31Abandoned005.7 mo
16263512INHIBITORS OF LEUKOTRIENE A4 HYDROLASE2019-01-31Abandoned105.7 mo
15891585DIAMINE DERIVATIVES AS INHIBITORS OF LEUKOTRIENE A4 HYDROLASE2018-02-08Abandoned106.9 mo
15274059Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15686082Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15326682Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15287311Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15448868Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15936732Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15400446Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 22 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in